Expression of hypoxia-inducible factor-1α and the protein products of its target genes in diabetic fibrovascular epiretinal membranes

被引:50
作者
Abu El-Asrar, Ahmed M.
Missotten, Luc
Geboes, Karel
机构
[1] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia
[2] Univ Louvain, Dept Ophthalmol, Louvain, Belgium
[3] Univ Louvain, Lab Histochem & Cytochem, Louvain, Belgium
关键词
D O I
10.1136/bjo.2006.109876
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Aims: To investigate the expression of the hypoxia-inducible factor-1 alpha (HIF-1 alpha) and the protein products of its target genes vascular endothelial growth factor ( VEGF), erythropoietin (Epo) and angiopoietins (Angs), and the antiangiogenic pigment epithelium-derived factor ( PEDF) in proliferative diabetic retinopathy (PDR) epiretinal membranes. Methods: Sixteen membranes were studied by immunohistochemical techniques. Results: Vascular endothelial cells expressed HIF-1 alpha, Ang-2 and VEGF in 15 (93.75%), 6 (37.5%) and 9 (56.25%) membranes, respectively. There was no immunoreactivity for Epo, Ang-1 and PEDF. There were significant correlations between the number of blood vessels expressing the panendothelial marker CD34 and the numbers of blood vessels expressing HIF-1 alpha (r = 0.554; p = 0.026), Ang-2 (r = 0.830; p < 0.001) and VEGF (r = 0.743; p = 0.001). The numbers of blood vessels expressing Ang-2 and VEGF in active membranes were higher than that in inactive membranes (p = 0.015 and 0.028, respectively). Conclusions: HIF-1 alpha, Ang-2 and VEGF may play an important role in the pathogenesis of PDR. The findings suggest an adverse angiogenic milieu in PDR epiretinal membranes favouring aberrant neovascularisation and endothelial abnormalities.
引用
收藏
页码:822 / 826
页数:5
相关论文
共 45 条
[1]
INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[2]
VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[3]
Bunn HF, 1998, J EXP BIOL, V201, P1197
[4]
Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats [J].
Chavez, JC ;
Almhanna, K ;
Berti-Mattera, LN .
NEUROSCIENCE LETTERS, 2005, 374 (03) :179-182
[5]
Pigment epithelium-derived factor: A potent inhibitor of angiogenesis [J].
Dawson, DW ;
Volpert, OV ;
Gillis, P ;
Crawford, SE ;
Xu, HJ ;
Benedict, W ;
Bouck, NP .
SCIENCE, 1999, 285 (5425) :245-248
[6]
Role of vascular endothelial growth factor in regulation of physiological angiogenesis [J].
Ferrara, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1358-C1366
[7]
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[8]
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization [J].
Gao, GQ ;
Li, Y ;
Zhang, DC ;
Gee, S ;
Crosson, C ;
Ma, JX .
FEBS LETTERS, 2001, 489 (2-3) :270-276
[9]
Hypoxia inducible factors 1α and 2α are associated with VEGF expression and angiogenesis in gallbladder carcinomas [J].
Giatromanolaki, A. ;
Sivridis, E. ;
Simopoulos, C. ;
Polychronidis, A. ;
Gatter, K. C. ;
Harris, A. L. ;
Koukourakis, M. I. .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (03) :242-247
[10]
Regulation of angiogenesis by hypoxia-inducible factor 1 [J].
Hirota, Kiichi ;
Semenza, Gregg L. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (01) :15-26